<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1130-0108</journal-id>
<journal-title><![CDATA[Revista Española de Enfermedades Digestivas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. esp. enferm. dig.]]></abbrev-journal-title>
<issn>1130-0108</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Patología Digestiva]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1130-01082018001200003</article-id>
<article-id pub-id-type="doi">10.17235/reed.2018.5468/2018</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Appropriateness of the use of proton pump inhibitors in the Emergency Department of a Spanish university hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Granero-Melcon]]></surname>
<given-names><![CDATA[Beatriz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morrás]]></surname>
<given-names><![CDATA[Ignacio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Galán-DeJuana]]></surname>
<given-names><![CDATA[Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Abad-Santos]]></surname>
<given-names><![CDATA[Francisco]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,La Princesa Health Research Institute (IP) Universidad Autónoma de Madrid (UAM) Clinical Pharmacology Department. Hospital Universitario La Princesa. Spanish Clinical Research Network (Plataforma SCReN). Biomedical Research Network of Hepatic and Digestive Diseases (CIBERehd). Teófilo Hernando Institute]]></institution>
<addr-line><![CDATA[Madrid ]]></addr-line>
<country>Spain</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Universitario Puerta de Hierro Majadahonda Internal Medicine Service ]]></institution>
<addr-line><![CDATA[Majadahonda, Madrid ]]></addr-line>
<country>Spain</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>110</volume>
<numero>12</numero>
<fpage>755</fpage>
<lpage>761</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1130-01082018001200003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1130-01082018001200003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1130-01082018001200003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Background:  the use of proton pump inhibitors (PPI) has increased substantially during the last years, possibly due to a significant proportion of prescriptions that do not follow the approved indications.  Objective:  to assess the prevalence of PPI prescription and the appropriateness of the prescription within the Emergency Department (ED) of a Spanish university hospital.  Materials and methods:  a cross-sectional, retrospective prescription-indication drug-use study was performed, which selected 384 patients that presented to the ED over two days in January 2016.  Results:  of the total cohort, 23.2% were taking PPI before their hospital visit and only 20.2% had a correct indication and dosage; 2.9% of the patient cohort had an indication for PPI treatment but had not been prescribed them. A drug other than omeprazole was used in 25% of cases; 30.47% of the patients were discharged with a PPI and only 28.2% of them had the correct indication and dosage. Finally, 5.7% were not prescribed PPI even though it was warranted. PPI prescription increased with age whereas the indication for the prescription decreased. Furthermore, the use of these drugs was higher in hospitalized patients compared to discharged patients.  Conclusions:  these results are in line with similar studies, which demonstrate the existence of an over-prescription of PPI. PPI prescription needs to be improved, thereby reducing drug interactions, adverse effects and unnecessary economical expenses.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Drug use studies]]></kwd>
<kwd lng="en"><![CDATA[Overuse]]></kwd>
<kwd lng="en"><![CDATA[Prescription]]></kwd>
<kwd lng="en"><![CDATA[Proton pump inhibitors]]></kwd>
<kwd lng="en"><![CDATA[Omeprazole]]></kwd>
<kwd lng="en"><![CDATA[Antiulcerous]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Subgrupos ATC y principios activos de mayor consumo en el Sistema Nacional de Salud en 2009]]></article-title>
<collab>Anonymous</collab>
<source><![CDATA[Información Terapéutica del Sistema Nacional de Salud]]></source>
<year>2010</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>124-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<collab>Spanish Agency of Medicines and Health Products</collab>
<source><![CDATA[Utilización de medicamentos antiulcerosos en España durante el periodo 2000-2012. Informe de utilización de medicamentos]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrera]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mataix]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<collab>Grupo de Recomendaciones en Farmacoterapia de la Comunidad de Madrid</collab>
<source><![CDATA[Criterios de selección de inhibidores de la bomba de protones]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Consejería de Sanidad, Servicio Madrileño de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estudio de utilización de antiulcerosos en España (2000-2008)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Inf Ter Sist Nac Salud]]></source>
<year>2009</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>49-54</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inhibidores de la bomba de protones. ¿Se puede vivir sin ellos? Información Farmacoterapéutica de la Comarca, Centro Vasco de Información de Medicamentos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agirrezabala]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Aizpurua]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Albizuri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[CEVIME/MIEZ]]></source>
<year>2010</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>11-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Practical considerations in the management of proton-pump inhibitors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguilera-Castro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Martín-de-Argila-de-Prados]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Albillos-Martínez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2016</year>
<volume>108</volume>
<page-range>145-53</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="">
<collab>Spanish Agency of Medicines and Health Products</collab>
<source><![CDATA[Drug labels of omeprazole, lansoprazole, rabeprazole, pantoprazole and esomeprazole]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Prado]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Criterios para la optimización en el uso de fármacos inhibidores de la bomba de protones]]></source>
<year>2015</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>85-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bañón]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Montes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Prescripción razonada de IBP. Boletín canario de uso racional del medicamento del Servicio Canario de Salud]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Consejería de Sanidad ]]></publisher-loc>
<publisher-name><![CDATA[Servicio Canario de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Encinas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lanas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Peña]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de la buena práctica clínica en protección gastrointestinal ante la ingesta de fármacos]]></source>
<year>2007</year>
<publisher-name><![CDATA[Ministerio de Sanidad y Consumo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estudio de prescripción-indicación de inhibidores de la bomba de protones]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Burgos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Novo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Llorente]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Clín Esp]]></source>
<year>2006</year>
<volume>206</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>266-70</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalencia de prescripción indicación de protectores gástricos en pacientes hospitalizados]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hermida]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabana]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Gac Sanit]]></source>
<year>2007</year>
<volume>21</volume>
<page-range>412-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluación del uso de los inhibidores de la bomba de protones en un servicio de medicina interna]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martín-Echevarría]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Torralba]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2008</year>
<volume>100</volume>
<page-range>76-81</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inappropriate prescribing of proton pump inhibitors in hospitalized patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Keinston]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hosp Med]]></source>
<year>2012</year>
<volume>7</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>421-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Overuse of PPIs in patients at admission, during treatment, and at discharge in a tertiary Spanish hospital]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lei]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Borobia]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Clin Pharmacol]]></source>
<year>2010</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>288-97</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazer-Amirshahi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mullins]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rising rates of proton pump inhibitor prescribing in US Emergency Departments]]></article-title>
<collab>Van den Anker J</collab>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2014</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>618-22</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Variabilidad en la práctica clínica, calidad de prescripción de los inhibidores de la bomba de protones]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanjosé-Rodríguez]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
<name>
<surname><![CDATA[Velarde-Mayol]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Calidad Asistencial]]></source>
<year>2012</year>
<volume>27</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>182-3</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proton pump inhibitor use in hospitalized patients is overutilization becoming a problem?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Durand]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Willett]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Desilets]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Med Insights Gastroenterol]]></source>
<year>2012</year>
<volume>5</volume>
<page-range>65-76</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Overprescribing proton pump inhibitors]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forgacs]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Loganayagam]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[BMJ]]></source>
<year>2008</year>
<volume>336</volume>
<numero>7634</numero>
<issue>7634</issue>
<page-range>2-3</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ahrens]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Behrens]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Himmel]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Clin Pract]]></source>
<year>2012</year>
<volume>66</volume>
<page-range>767-73</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[IV Conferencia Espanola de Consenso sobre el tratamiento de la infección por Helicobacter pylori]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gisbert]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Molina-Infante]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Amador]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2016</year>
<volume>39</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>697-721</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery a systematic review and meta-analysis of cohort studies]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ying]]></surname>
<given-names><![CDATA[VW]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Surg Endosc]]></source>
<year>2015</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1018-23</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gumbs]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Duffy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Surg Obes Relat Dis]]></source>
<year>2006</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>460-3</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inhibidores de la bomba de protones y el balance riesgo-beneficio]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Madridejos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Butlletí d'informació terapèutica]]></source>
<year>2013</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>7-11</page-range><publisher-name><![CDATA[Generalitat de Catalunya, Departament de Salut]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proton pump inhibitor therapy and potential long-term harm]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corleto]]></surname>
<given-names><![CDATA[VD]]></given-names>
</name>
<name>
<surname><![CDATA[Festa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Di Giulio]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Opin Endocrinol Diabetes Obes]]></source>
<year>2014</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Reported side effects and complications of long-term proton pump inhibitor use]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Oldfield 4th]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Gastroenterol Hepatol]]></source>
<year>2013</year>
<volume>11</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>458-64</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proton pump inhibitors are they overutilised in clinical practice and do they pose significant risk?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heidelbaugh]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Metz]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[XY]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Clin Pract]]></source>
<year>2012</year>
<volume>66</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>582-91</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding effect of standardized guidelines on prescribing practice]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yachimski]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Farrell]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Intern Med]]></source>
<year>2010</year>
<volume>170</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>779-83</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Atkins]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Consult Pharm]]></source>
<year>2013</year>
<volume>28</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>786-92</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
